Skip to content

Develop and validate an endoscopic scoring method for assessing the severity and prognosis of small intestinal lesions in patients with Crohn's disease

Develop and validate an endoscopic scoring method for assessing the severity and prognosis of small intestinal

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500097976
Enrollment
Unknown
Registered
2025-02-28
Start date
2025-02-28
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn’s disease

Interventions

Observation group:None

Sponsors

The First Affiliated Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age between 14-75 years old, male and female; 2. Patients diagnosed with Crohn's disease based on clinical manifestations, laboratory examinations, imaging examinations, endoscopic and histopathological examinations; 3. The patient underwent double balloon enteroscopy (DBE) examination before formal treatment ( 52 weeks.

Exclusion criteria

Exclusion criteria: 1. Patients diagnosed with ulcerative colitis, inflammatory bowel disease - unclassified; 2. Have previously undergone bowel resection or intra-abdominal surgery; 3. Patients with active malignant tumors, severe hepatic and renal insufficiency, severe cardiopulmonary diseases or systemic infectious diseases; 4. Pregnant, breastfeeding, or planning to become pregnant during the enrollment study period.

Design outcomes

Primary

MeasureTime frame
Scoring of double-balloon small enteroscopy;

Secondary

MeasureTime frame
SES-CD sore;Fecal calprotectin;

Countries

China

Contacts

Public ContactLan Li

The First Affiliated Hospital, Zhejiang University School of Medicine

doctorlilan@163.com+86 571 8723 6861

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026